These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18397747)

  • 41. Possibility of insulin-producing cells derived from mouse embryonic stem cells for diabetes treatment.
    Ibii T; Shimada H; Miura S; Fukuma E; Sato H; Iwata H
    J Biosci Bioeng; 2007 Feb; 103(2):140-6. PubMed ID: 17368396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD24: a novel surface marker for PDX1-positive pancreatic progenitors derived from human embryonic stem cells.
    Jiang W; Sui X; Zhang D; Liu M; Ding M; Shi Y; Deng H
    Stem Cells; 2011 Apr; 29(4):609-17. PubMed ID: 21308865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Definitive endoderm: a key step in coaxing human embryonic stem cells into transplantable beta-cells.
    Semb H
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):272-5. PubMed ID: 18481940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathway decision-making strategies for generating pancreatic beta-cells: systems biology or hit and miss?
    Jensen J
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):277-82. PubMed ID: 17940452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiation of embryonic and adult stem cells into insulin producing cells.
    Zulewski H
    Panminerva Med; 2008 Mar; 50(1):73-9. PubMed ID: 18427390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of insulin-producing cells from primitive biologic precursors.
    Evans-Molina C; Vestermark GL; Mirmira RG
    Curr Opin Organ Transplant; 2009 Feb; 14(1):56-63. PubMed ID: 19337148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell therapy for diabetes mellitus: an opportunity for stem cells?
    Soria B; Bedoya FJ; Tejedo JR; Hmadcha A; Ruiz-Salmerón R; Lim S; Martin F
    Cells Tissues Organs; 2008; 188(1-2):70-7. PubMed ID: 18305378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancreatic stem cells: differentiation options.
    Rao MS; Reddy JK
    Stem Cell Rev; 2005; 1(3):265-71. PubMed ID: 17142864
    [No Abstract]   [Full Text] [Related]  

  • 49. Toward a cell-based cure for diabetes: advances in production and transplant of beta cells.
    Claiborn KC; Stoffers DA
    Mt Sinai J Med; 2008 Aug; 75(4):362-71. PubMed ID: 18729181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracellular matrix-mediated differentiation of human embryonic stem cells: differentiation to insulin-secreting beta cells.
    Narayanan K; Lim VY; Shen J; Tan ZW; Rajendran D; Luo SC; Gao S; Wan AC; Ying JY
    Tissue Eng Part A; 2014 Jan; 20(1-2):424-33. PubMed ID: 24020641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation of human embryonic stem cells into pancreatic endoderm in patterned size-controlled clusters.
    Van Hoof D; Mendelsohn AD; Seerke R; Desai TA; German MS
    Stem Cell Res; 2011 May; 6(3):276-85. PubMed ID: 21513906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of embryonic stem cells from mouse insulin I promoter-green fluorescent protein transgenic mice and characterization in a teratoma model.
    Milewski WM; Temple KA; Wesselschmidt RL; Hara M
    In Vitro Cell Dev Biol Anim; 2009; 45(1-2):1-5. PubMed ID: 18855079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies.
    Hentze H; Soong PL; Wang ST; Phillips BW; Putti TC; Dunn NR
    Stem Cell Res; 2009 May; 2(3):198-210. PubMed ID: 19393593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scalable production of pancreatic islet progenitors for diabetes cell therapies.
    Lock LT; Tzanakakis ES
    Med J Malaysia; 2008 Jul; 63 Suppl A():5-6. PubMed ID: 19024957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient definitive endoderm induction from mouse embryonic stem cell adherent cultures: a rapid screening model for differentiation studies.
    Mfopou JK; Geeraerts M; Dejene R; Van Langenhoven S; Aberkane A; Van Grunsven LA; Bouwens L
    Stem Cell Res; 2014 Jan; 12(1):166-77. PubMed ID: 24239964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In search of a surrogate: engineering human beta cell lines for therapy.
    Newby BN; Terada N; Mathews CE
    Trends Endocrinol Metab; 2014 Aug; 25(8):378-80. PubMed ID: 24958526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regeneration of pancreatic beta cells.
    Jun HS
    Front Biosci; 2008 May; 13():6170-82. PubMed ID: 18508651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells.
    Bruin JE; Erener S; Vela J; Hu X; Johnson JD; Kurata HT; Lynn FC; Piret JM; Asadi A; Rezania A; Kieffer TJ
    Stem Cell Res; 2014 Jan; 12(1):194-208. PubMed ID: 24257076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures.
    Fukazawa T; Matsuoka J; Naomoto Y; Nakai T; Durbin ML; Kojima I; Lakey JR; Tanaka N
    Exp Cell Res; 2006 Oct; 312(17):3404-12. PubMed ID: 16934249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic stem cells remain unresolved.
    Jiang FX; Morahan G
    Stem Cells Dev; 2014 Dec; 23(23):2803-12. PubMed ID: 25132582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.